This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 02, 2018.(b)(4).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
This follow-up report is submitted to fda in accord with applicable regulations.(b)(4).The returned sample was visually inspected and dried blood was noted upon receipt.The sample was returned without the sparger assembly and the white cap.The returned sample was leak tested (as received) by connecting with the calibrated manometer, submerged into a water bath, and pressurized up to 1030 mmhg, and no leaks were noted.This is most likely attributed to the dried blood within the sensor body and connection threads to the large blue cap.The shunt sensor was then soaked in a di water for 24 hours.The large bore adapter blue cap was then loosened and re-tightened by hand.The sample was leak tested on a second time by connecting with the calibrated manometer, submerged into a water bath, and pressurized up to 1030 mmhg, and no leaks were noted.A retention sample was unable to be tested because a lot number was not provided.The root cause for this event was determined to be the large blue vent cap for shunt sensor was not fully tightened either during setup of the circuit, or after the gas calibration.When the large blue vent cap was loosened, it had not been re-tightened fully prior to use in the line, causing a leak from the cap.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|